BOBULSKY SUSAN sold $60K of ADPT
BOBULSKY SUSAN (Chief Commercial Officer, MRD) sold 1,875 shares of Adaptive Biotechnologies Corp (ADPT) at $32.00 on 2026-11-11 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
Small insider sale unlikely to move price materially but may be noted by quantitative traders.
Market read
Routine insider sale with limited trading relevance.
What to watch
Potential upcoming corporate developments not disclosed.
Background
SEC Form 4 filing discloses insider transactions required by regulation.
Ticker impact
Form 4 shows Chief Commercial Officer Susan Bobulsky sold 1,875 shares for $60,000 via a 10b5‑1 plan.
likely modest pressure as the market prices in the insider sale
The sale is small relative to holdings and executed under a pre‑arranged plan, so impact is limited but could cause minor downside bias.
Market effects
Minimal effect on biotech sector; typical insider sales are routine.
None
None
Counterpoint
Sale could be unrelated to fundamentals; investors may ignore.
Key entities
- CompanyAdaptive Biotechnologies Corp
NASDAQ‑listed biotech firm.
- ExecutiveSusan Bobulsky
Chief Commercial Officer, MRD.



